Organon Co (OGN)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Dividendenhistorie

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Organon Co Stock (OGN) Company Profile

Healthcare (1163)

551-430-6000

30 HUDSON STREET, JERSEY CITY

Nächster Verdiensttermin

Neueste SEC-Einreichungen

OGN's Discussions on Twitter

Vergleichen Sie OGN mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
OGN Organon Co	15.62	4.03B	6.41B	1.30B	646.00M	5.04
LLY Lilly Eli Co	841.61	754.10B	45.04B	10.59B	414.30M	11.71
ABBV Abbvie Inc	210.01	374.57B	56.33B	4.28B	17.83B	2.40
NVO Novo Nordisk Adr	76.93	338.61B	42.09B	14.65B	10.11B	3.2833
JNJ Johnson Johnson	163.46	344.63B	88.82B	14.07B	18.06B	5.79
MRK Merck Co Inc	93.41	238.10B	64.17B	17.12B	18.10B	6.73

Organon Co Stock (OGN) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-09-06	Herabstufung	JP Morgan	Neutral → Underweight
2023-11-03	Herabstufung	Goldman	Buy → Neutral
2023-09-21	Eingeleitet	Barclays	Overweight
2023-03-16	Eingeleitet	Raymond James	Outperform
2022-10-14	Herabstufung	BofA Securities	Neutral → Underperform
2022-09-06	Hochstufung	Piper Sandler	Neutral → Overweight
2022-08-05	Herabstufung	BofA Securities	Buy → Neutral
2022-04-27	Eingeleitet	Goldman	Buy
2022-04-06	Fortgesetzt	Morgan Stanley	Equal-Weight
2021-10-07	Eingeleitet	Piper Sandler	Neutral
2021-09-01	Eingeleitet	BofA Securities	Buy
2021-07-22	Eingeleitet	Citigroup	Buy
2021-06-15	Eingeleitet	JP Morgan	Neutral
2021-06-11	Eingeleitet	Morgan Stanley	Equal-Weight
2021-06-10	Eingeleitet	Evercore ISI	Outperform

Alle ansehen

Organon Co Aktie (OGN) Neueste Nachrichten

Finanzdaten der Organon Co-Aktie (OGN)

Organon Co (OGN)

Organon Co Stock (OGN) Company Profile

Vergleichen Sie OGN mit anderen Aktien

Organon Co Stock (OGN) Upgrades & Downgrades

Organon Co Aktie (OGN) Neueste Nachrichten

Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

Organon (OGN): Company Profile, Stock Price, News, Rankings - Fortune

Organon (OGN) Advances While Market Declines: Some Information for Investors - MSN

Why Organon Is A Top Pick For Income Investors (NYSE:OGN) - Seeking Alpha

Is Organon & Co. (OGN) the Deep Value Stock to Buy Now? - Insider Monkey

Organon & Co. (NYSE:OGN) Receives $20.80 Consensus Target Price from Analysts - Defense World

Organon & Co. (NYSE:OGN) Shares Sold by US Bancorp DE - Defense World

Organon & Co (OGN) Trading Down 2.88% on Mar 12 - GuruFocus.com

Organon’s SWOT analysis: stock poised for growth amid challenges By Investing.com - Investing.com Australia

Organon’s SWOT analysis: stock poised for growth amid challenges - Investing.com India

Trend Tracker for (OGN) - Stock Traders Daily

Proficio Capital Partners LLC Acquires New Holdings in Organon & Co. (NYSE:OGN) - Defense World

Healthcare Veteran Appointed CEO of May Health's Groundbreaking PCOS Technology - StockTitan

New Analysis of Organon’s VTAMA® (tapinarof) cream, 1% Phase 3 Data Shows Atopic Dermatitis Disease Activity Remained Low After Treatment-Free Interval in Adults and Children 2 Years of Age and Older - BioSpace

MAY HEALTH APPOINTS SEASONED MEDTECH EXECUTIVE, COLBY HOLTSHOUSE, AS PRESIDENT AND CEO - Quantisnow

Organon announes results from analysis of Phase 3 ADORING 3 study - TipRanks

Can This Skin Treatment Work for Months After Stopping? New Clinical Data Reveals Surprising Results - StockTitan

Organon and Partners Advance Women’s Health Innovation to Drive Economic and Social Growth in Southeast Asia - The Hastings Tribune

Organon and partners drive innovation to strengthen healthcare access - Bangkok Post

Organon & Co. (NYSE:OGN) Shares Sold by Private Advisor Group LLC - Defense World

Truist Financial Corp Increases Stock Holdings in Organon & Co. (NYSE:OGN) - Defense World

(OGN) Long Term Investment Analysis - Stock Traders Daily

Principal Financial Group Inc. Raises Stock Position in Organon & Co. (NYSE:OGN) - MarketBeat

New York State Common Retirement Fund Buys 43,928 Shares of Organon & Co. (NYSE:OGN) - MarketBeat

Organon & Co. (NYSE:OGN) Shares Up 5.7%Here's What Happened - MarketBeat

A&I Financial Services LLC Invests $402,000 in Organon & Co. (NYSE:OGN) - MarketBeat

Is Organon & Co. (OGN) the Best Low Price Pharma Stock to Invest In Right Now? - Insider Monkey

Rhumbline Advisers Sells 14,051 Shares of Organon & Co. (NYSE:OGN) - Defense World

Principal Financial Group Inc. Buys 32,485 Shares of Organon & Co. (NYSE:OGN) - Defense World

The Hidden Gems of the Pharma World: Stocks Analysts Can’t Ignore - jomfruland.net

Organon & Co. (OGN): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts - Insider Monkey

10 Cheap Pharmaceutical Stocks to Buy According to Analysts - Insider Monkey

Allspring Global Investments Holdings LLC Increases Holdings in Organon & Co. (NYSE:OGN) - MarketBeat

New York State Teachers Retirement System Has $4.61 Million Holdings in Organon & Co. (NYSE:OGN) - Defense World

Savant Capital LLC Sells 88,315 Shares of Organon & Co. (NYSE:OGN) - MarketBeat

Organon's SWOT analysis: women's health leader faces biosimilar growth, LOE challenges - MSN

Organon announces departure of chief commercial officer - MSN

Philip James Wealth Mangement LLC Has $12.99 Million Holdings in Organon & Co. (NYSE:OGN) - MarketBeat

Finanzdaten der Organon Co-Aktie (OGN)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie OGN